NEW YORK, July 26, 2019 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (AMRX) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that Amneal was involved in anticompetitive practices. If you are an AMRX investor, and would like...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]roup-inc-maxar-technologies-in